Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Behavioural Brain Research

• Publication date

  2012-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbr.2012.01.044PMID 22309983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RGSZ2 Binds to the Neural Nitric Oxide Synthase PDZ Domain to Regulate Mu-Opioid Receptor-Mediated Potentiation of the N-Methyl-D-Aspartate Receptor-Calmodulin-Dependent Protein Kinase II Pathway

  2011cited by this paper
• Perturbing PSD-95 Interactions With NR2B-subtype Receptors Attenuates Spinal Nociceptive Plasticity and Neuropathic Pain

  2011cited by this paper
• Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats

  2010cited by this paper
• Valproate and Amitriptyline Exert Common and Divergent Influences on Global and Gene Promoter-Specific Chromatin Modifications in Rat Primary Astrocytes

  2010cited by this paper
• Purinergic P2X Receptor Regulates N-Methyl-d-aspartate Receptor Expression and Synaptic Excitatory Amino Acid Concentration in Morphine-tolerant Rats

  2010cited by this paper
• The neuropathy-protective agent acetyl-L-carnitine activates protein kinase C-gamma and MAPKs in a rat model of neuropathic pain.

  2010cited by this paper
• Modulation of sensory neuron‐specific receptors in the development of morphine tolerance and its neurochemical mechanisms

  2010cited by this paper
• In Vivo Composition of NMDA Receptor Signaling Complexes Differs between Membrane Subdomains and Is Modulated by PSD-95 And PSD-93

  2010cited by this paper
• Mu-Opioid Receptors Transiently Activate the Akt-nNOS Pathway to Produce Sustained Potentiation of PKC-Mediated NMDAR-CaMKII Signaling

  2010cited by this paper
• Gene knockdown with lentiviral vector‐mediated intrathecal RNA interference of protein kinase C gamma reverses chronic morphine tolerance in rats

  2010cited by this paper
• Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.

  2010cited by this paper
• Glutamate‐mediated astrocyte‐to‐neuron signalling in the rat dorsal horn

  2010cited by this paper
• NMDA receptors are involved in upstream of the spinal JNK activation in morphine antinociceptive tolerance.

  2009cited by this paper
• Plasticity of NMDA receptor NR2B subunit in memory and chronic pain

  2009cited by this paper
• Amitriptyline Suppresses Neuroinflammation-dependent Interleukin-10-p38 Mitogen-activated Protein Kinase-Heme Oxygenase-1 Signaling Pathway in Chronic Morphine-infused Rats

  2009cited by this paper
• NFLAMMATORY PAIN-INDUCED SIGNALING EVENTS FOLLOWING A ONDITIONAL DELETION OF THE N-METHYL-D-ASPARTATE ECEPTOR IN SPINAL CORD DORSAL HORN

  2008cited by this paper
• N‐Methyl‐d‐aspartate receptor antagonist MK‐801 attenuates morphine tolerance and associated glial fibrillary acid protein up‐regulation: a proteomic approach

  2008cited by this paper
• Developmental regulation of PSD-95 and nNOS expression in lumbar spinal cord of rats.

  2008cited by this paper
• The glycine site-specific NMDA antagonist (+)-HA966 enhances the effect of morphine and reverses morphine tolerance via a spinal mechanism.

  2008cited by this paper
• Intrathecal Clonidine Suppresses Phosphorylation of the N-Methyl-D-Aspartate Receptor NR1 Subunit in Spinal Dorsal Horn Neurons of Rats with Neuropathic Pain

  2008cited by this paper
• HIV-tat induces formation of an LRP–PSD-95– NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes

  2007cited by this paper
• Amitriptyline preserves morphine’s antinociceptive effect by regulating the glutamate transporter GLAST and GLT‐1 trafficking and excitatory amino acids concentration in morphine‐tolerant rats

  2007cited by this paper
• Involvement of the protein kinase Cγ isoform in development of tolerance to nitrous oxide–induced antinociception in mice

  2007cited by this paper
• Amitriptyline induces early growth response-1 gene expression via ERK and JNK mitogen-activated protein kinase pathways in rat C6 glial cells.

  2007cited by this paper
• Synergistic Control of Protein Kinase Cγ Activity by Ionotropic and Metabotropic Glutamate Receptor Inputs in Hippocampal Neurons

  2006cited by this paper
• Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia.

  2006cited by this paper
• PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating

  2006cited by this paper
• [Role of astrocytes in rewarding effects of drugs of abuse].

  2006cited by this paper
• Amitriptyline suppresses neuroinflammation and up‐regulates glutamate transporters in morphine‐tolerant rats

  2006cited by this paper
• Expression of Spinal NMDA Receptor and PKCγ after Chronic Morphine Is Regulated by Spinal Glucocorticoid Receptor

  2005cited by this paper
• Dexamethasone modulates the development of morphine tolerance and expression of glutamate transporters in rats.

  2005cited by this paper
• Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures.

  2005cited by this paper
• Expression of spinal NMDA receptor and PKCgamma after chronic morphine is regulated by spinal glucocorticoid receptor.

  2005cited by this paper
• An Antisense Oligonucleotide to the N-Methyl-d-aspartate (NMDA) Subunit NMDAR1 Attenuates NMDA-Induced Nociception, Hyperalgesia, and Morphine Tolerance

  2005cited by this paper
• PDZ domain proteins of synapses

  2004cited by this paper
• The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice.

  2004cited by this paper
• Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats.

  2004cited by this paper
• Postsynaptic Density Protein-95 Regulates NMDA Channel Gating and Surface Expression

  2004cited by this paper
• Opioid abuse and brain gene expression.

  2004cited by this paper
• Neuronal protein kinase Cγ‐dependent proliferation and hypertrophy of spinal cord astrocytes following repeated in vivo administration of morphine

  2004cited by this paper
• Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614.

  2003cited by this paper
• D-2-amino-5-phosphonopentanoic acid inhibits intrathecal pertussis toxin-induced thermal hyperalgesia and protein kinase Cgamma up-regulation.

  2003cited by this paper
• A Conditional Deletion of the NR1 Subunit of the NMDA Receptor in Adult Spinal Cord Dorsal Horn Reduces NMDA Currents and Injury-Induced Pain

  2003cited by this paper
• Chronic Morphine Induces Downregulation of Spinal Glutamate Transporters: Implications in Morphine Tolerance and Abnormal Pain Sensitivity

  2002cited by this paper
• The Role of Spinal Neuroimmune Activation in Morphine Tolerance/Hyperalgesia in Neuropathic and Sham-Operated Rats

  2002cited by this paper
• NMDA receptor subunits: diversity, development and disease.

  2001cited by this paper
• Involvement of Spinal Protein Kinase Cγ in the Attenuation of Opioid μ-Receptor-Mediated G-Protein Activation after Chronic Intrathecal Administration of [d-Ala2,N-MePhe4,Gly-Ol5]Enkephalin

  2001cited by this paper
• Convergence of PKC-dependent kinase signal cascades on NMDA receptors.

  2001cited by this paper
• PSD-95 involvement in maturation of excitatory synapses.

  2000cited by this paper
• Morphine tolerance increases [3H]MK‐801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord

  2000cited by this paper
• Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.

  2000cited by this paper
• Effects of Amitriptyline, Amitriptylinoxide, Doxepine and Clozapine on N-Methyl-D-aspartate-evoked Release of [3H]-Acetylcholine in Rat Caudatoputamen

  1999cited by this paper
• Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein.

  1999cited by this paper
• PSD-95 Assembles a Ternary Complex with theN-Methyl-d-aspartic Acid Receptor and a Bivalent Neuronal NO Synthase PDZ Domain*

  1999cited by this paper
• Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains.

  1996cited by this paper
• Glia-neuron intercommunications and synaptic plasticity.

  1996cited by this paper
• Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.

  1996cited by this paper
• N-Methyl-D-Aspartate (NMDA) Receptors, Mu and Kappa Opioid Tolerance, and Perspectives on New Analgesic Drug Development

  1995cited by this paper
• Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy.

  1995cited by this paper
• Intrathecal Amitriptyline Acts as an N‐Methyl‐D‐Aspartate Receptor Antagonist in the Presence of Inflammatory Hyperalgesia in Rats

  1995cited by this paper
• Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95.

  1995cited by this paper
• Perspectives on the N-Methyl-D-Aspartate/Nitric Oxide Cascade and Opioid Tolerance

  1995cited by this paper
• Structure and function of the NMDA receptor channel.

  1995cited by this paper
• Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture.

  1992cited by this paper
• Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid.

  1991cited by this paper

• Assessing Blood-Brain Barrier Function in the Context of Pain Management.

  2024cites this paper
• Neuroinflammation in the Pathogenesis of Neuropathic Pain Syndrome

  2023cites this paper
• Revolutionizing orofacial pain management: the promising potential of stem cell therapy

  2023cites this paper
• [Neuroinflammation in the pathogenesis of central neuropathic pain].

  2022cites this paper
• Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain

  2022cites this paper
• Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966

  2022cites this paper
• Viral vector-mediated gene therapy for opioid use disorders.

  2021cites this paper
• Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine‐3‐glucuronide and morphine‐6‐glucuronide in human astrocytes

  2020cites this paper
• Reactive Oxygen Species (ROS) are Critical for Morphine Exacerbation of HIV-1 gp120-Induced Pain

  2020cites this paper
• Targeting Cytokines for Morphine Tolerance: A Narrative Review

  2019cites this paper
• Morphine and HIV-1 gp120 cooperatively promote pathogenesis in the spinal pain neural circuit

  2019cites this paper
• Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain

  2016cites this paper
• Further observations on the behavioral and neural effects of bone marrow stromal cells in rodent pain models

  2016cites this paper
• Astrocytic expression of GFAP and serum levels of IL-1β and TNF-α in rats treated with different pain relievers

  2016cites this paper
• Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model.

  2015cites this paper
• Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: A randomised laboratory study

  2015cites this paper
• Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.

  2015cites this paper
• Identification of a Novel Spinal Dorsal Horn Astroglial D-Amino Acid Oxidase–Hydrogen Peroxide Pathway Involved in Morphine Antinociceptive Tolerance

  2014cites this paper
• Enhancement of antinociceptive effect of morphine by antidepressants in diabetic neuropathic pain model

  2014cites this paper
• New insights into enhancing morphine analgesia: from glia to pharmacokinetics

  2014influential citation
• The role of the blood–brain barrier in the development and treatment of migraine and other pain disorders

  2014cites this paper
• Amitriptyline up‐regulates connexin43‐gap junction in rat cultured cortical astrocytes via activation of the p38 and c‐Fos/AP‐1 signalling pathway

  2014cites this paper
• Role of oxidative stress and inducible nitric oxide synthase in morphine-induced tolerance and dependence in mice. Effect of alpha-lipoic acid.

  2013cites this paper
• Endogenous opiates and behavior: 2012.

  2013cites this paper
• Ultra-low dose (+)-naloxone restores the thermal threshold of morphine tolerant rats.

  2013cites this paper
• Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.

  2013cites this paper
• Inhibition of brain oxidative stress and inducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice.

  2013cites this paper
• Proteomic Analysis of PKCγ-Related Proteins in the Spinal Cord of Morphine-Tolerant Rats

  2012cites this paper